These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1957857)

  • 1. Amniotic fluid contains tissue factor, a potent initiator of coagulation.
    Lockwood CJ; Bach R; Guha A; Zhou XD; Miller WA; Nemerson Y
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1335-41. PubMed ID: 1957857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of coagulation in amniotic fluid during normal human pregnancy.
    Sarig G; Klil-Drori AJ; Chap-Marshak D; Brenner B; Drugan A
    Thromb Res; 2011 Nov; 128(5):490-5. PubMed ID: 21504838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J
    Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):163-6. PubMed ID: 11301162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procoagulant activity and phosphatidylserine of amniotic fluid cells.
    Zhou J; Liu S; Ma M; Hou J; Yu H; Lu C; Gilbert GE; Shi J
    Thromb Haemost; 2009 May; 101(5):845-51. PubMed ID: 19404537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation and fibrinolysis in amniotic fluid: physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia.
    Uszyński M; Uszyński W
    Semin Thromb Hemost; 2011 Mar; 37(2):165-74. PubMed ID: 21370219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New observations on procoagulant properties of amniotic fluid: microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma.
    Uszyński W; Zekanowska E; Uszyński M; Zyliński A; Kuczyński J
    Thromb Res; 2013; 132(6):757-60. PubMed ID: 24157083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procoagulant activity and cellular origin of microparticles in human amniotic fluid.
    Liu S; Wei L; Zhang Y; Xu M; Wang C; Zhou J
    Thromb Res; 2014 Apr; 133(4):645-51. PubMed ID: 24439679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
    Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
    J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous injection of autologous amniotic fluid induces transient thrombocytopenia in a gravid rabbit model of amniotic fluid embolism.
    Rannou B; Rivard GE; Gains MJ; Bédard C
    Vet Clin Pathol; 2011 Dec; 40(4):524-529. PubMed ID: 22092306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of the thromboplastic activity of amniotic fluid with Trasylol].
    Slunsky R
    Gynakol Rundsch; 1973; 13(2):147-52. PubMed ID: 4542664
    [No Abstract]   [Full Text] [Related]  

  • 11. Procoagulant properties of amniotic fluid.
    Phillips LL; Davidson EC
    Am J Obstet Gynecol; 1972 Aug; 113(7):911-9. PubMed ID: 4635740
    [No Abstract]   [Full Text] [Related]  

  • 12. Amniotic fluid embolism: the complication of known pathomechanism but without pathogenetic therapy?
    Uszynski M
    Thromb Haemost; 2009 May; 101(5):795-6. PubMed ID: 19404526
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the procoagulant activity of human amniotic fluid. II. The role of factor VII.
    Pusey ML; Mende TJ
    Thromb Res; 1985 Sep; 39(5):571-85. PubMed ID: 3936221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ON POSSIBLE INTERFERENCE OF MECONIUM IN THE PATHOGENESIS OF OBSTETRICAL COAGULATION DISORDERS].
    MENTASTI P; RUGIATI S
    Minerva Ginecol; 1964 Jan; 16():10-4. PubMed ID: 14124183
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism).
    Levi M
    Thromb Res; 2013 Jan; 131 Suppl 1():S32-4. PubMed ID: 23452737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AMNIOTIC FLUID EMBOLISM AS A CAUSE OF BLOOD COAGULATION DISORDER].
    SLUNSKY R; MIREJOVSKY P
    Zentralbl Gynakol; 1963 Sep; 85():1396-404. PubMed ID: 14091202
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoprotein associated coagulation inhibitor, factor VII, antithrombin III, and monocyte tissue factor following surgery.
    Carson SD; Haire WD; Broze GJ; Novotny WF; Pirrucello SJ; Duggan MJ
    Thromb Haemost; 1991 Nov; 66(5):534-9. PubMed ID: 1803617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of human platelets by amniotic fluid.
    Salem HH; Walters WA; Perkin JL; Handley CJ; Firkin BG
    Br J Obstet Gynaecol; 1982 Sep; 89(9):733-7. PubMed ID: 7115637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy.
    Sandset PM; Hellgren M; Uvebrandt M; Bergström H
    Thromb Res; 1989 Sep; 55(5):665-70. PubMed ID: 2814949
    [No Abstract]   [Full Text] [Related]  

  • 20. Amniotic fluid embolism during caesarean section.
    Tramoni G; Valentin S; Robert MO; Sergeant MV; Branche P; Duperret S; Clement HJ; Lopez F; Boisson C; Audra P; Rudigoz RC; Viale JP
    Int J Obstet Anesth; 2004 Oct; 13(4):271-4. PubMed ID: 15477060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.